|
Video: What is a Stock Split?
|
|
Synergy Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of gastrointestinal (GI) therapies. Co. is engaged in the discovery, research and development activities around analogs of uroguanylin, a naturally occurring and endogenous human GI peptide, for the treatment of GI diseases and disorders. Co. discovered, is developing and controls 100% worldwide rights to its proprietary uroguanylin analog platform. Co.'s commercial product, plecanatide, under trademark name TRULANCE is for the treatment of adults with chronic idiopathic constipation and irritable bowel syndrome with constipation. According to our SGYP split history records, SGYP has had 1 split. | |
|
SGYP (SGYP) has 1 split in our SGYP split history database. The split for SGYP took place on February 11, 2014. This was a 1014 for 1000 split, meaning for each 1000 shares of SGYP owned pre-split, the shareholder now owned 1014 shares. For example, a 1000 share position pre-split, became a 1014 share position following the split.
When a company such as SGYP splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business.
Looking at the SGYP split history from start to finish, an original position size of 1000 shares would have turned into 1014 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into SGYP shares, starting with a $10,000 purchase of SGYP, presented on a split-history-adjusted basis factoring in the complete SGYP split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
03/31/2014 |
|
End date: |
04/08/2019 |
|
Start price/share: |
$5.31 |
|
End price/share: |
$0.03 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-99.44% |
|
Average Annual Total Return: |
-64.30% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$56.53 |
|
Years: |
5.02 |
|
|
|
Date |
Ratio |
02/11/2014 | 1014 for 1000 |
|
|